New drug shows promise in controlling lung cancer growth
NCT ID NCT05735327
First seen Apr 15, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This study looks at how well the drug brigatinib works in adults with a specific type of lung cancer (ALK-positive NSCLC). Researchers will track how long the cancer stays under control and how many patients respond to treatment. About 50 participants will receive brigatinib as part of their regular care, with data collected during up to 12 hospital visits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centrum Onkologii im.Prof. F. Lukaszczyka w Bydgoszczy
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-796, Poland
-
Centrum Pulmonologii i Torakochirurgii w Bystrej
Bystra, Slskie, 43-360, Poland
-
Dolnoslskie Centrum Onkologii, Pulmonologii i Hematologii
Wroclaw, Dolnoslskie, 53-413, Poland
-
Instytut Gruzlicy i Chorob Pluc
Warsaw, Masovian Voivodeship, 01-138, Poland
-
Krakowski Szpital Specjalistyczny im. Jana Pawla II w Krakowie
Krakow, Lesser Poland Voivodeship, 31-202, Poland
-
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie, Panstwowy Instytut Badawczy
Warsaw, Masovian Voivodeship, 02-781, Poland
-
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie- Panstwowy Instytut Badawczy Oddzial w Krakowie
Krakow, Lesser Poland Voivodeship, 31-115, Poland
-
Podkarpackie Centrum Chorob Pluc
Rzeszów, Podkarpackie Voivodeship, 35-241, Poland
-
SPZOZ Uniwersytecki Szpital Kliniczny nr 2 im. Wojskowej Akademii Medycznej Uniwersytetu Medycznego w Lodzi Centralny Szpital Weteranow
Lodz, Łódź Voivodeship, 90-549, Poland
-
Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie
Lublin, Lublin Voivodeship, 20-954, Poland
-
Szpital Kliniczny im. Heliodora Swiecickiego UM wPoznaniu.
Poznan, Greater Poland Voivodeship, 60-355, Poland
-
Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu
Poznan, Greater Poland Voivodeship, 60-569, Poland
Conditions
Explore the condition pages connected to this study.